RECENT NEWS

Digital and computational pathology solution firm Proscia has announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Concentriq AP-Dx. The digital pathology solution was cleared for the purpose of primary diagnosis.

The blood transfusion service in Leeds Teaching Hospitals NHS Trust has started working with a new LIMS, as part of a larger project to deploy a single LIMS across the West Yorkshire Association of Acute Trusts.

Digital pathology firm Paige has announced a significant expansion of its AppLab marketplace, with the addition of six new digital pathology and AI providers. New applications from Imagene, Histofy, Aiosyn, Clinsight, DoMore Diagnostics, and Stratipath, will be added to the AppLab to provide support for pathology laboratories worldwide in building deeply integrated and customised AI-enabled workflows.

Cancer diagnostics company Veracyte has announced it has completed its acquisition of C2i Genomics, adding whole-genome minimal residual disease (MRD) capabilities to its novel diagnostics platform and expanding the company’s ability to serve patients across the cancer care continuum.

Alpha Laboratories has made a further step in its drive to reduce the environmental impact of laboratory consumables with the introduction of FastZAP filter tip refills, which the company says represent a significant step forward in sustainability, while maintaining the quality and performance expected from ZAP premier filter tips.

Beckman Coulter Diagnostics has appointed Kevin O’Reilly as its new president, succeeding Julie Sawyer Montgomery, who is now vice president and group executive at Danaher Diagnostics.

NICE has updated its guidance for suspected sepsis, recommending better targeting of antibiotics to ensure the right people receive treatment as soon as possible but the medicines are not overused, which can lead to antibiotic resistance.

The British In Vitro Diagnostics Association (BIVDA) has announced the appointment of Professor Mike Messenger as Head of Regulatory Strategy from 1 March 2024.

Source Genomics, a part of the Source BioScience Group, has expanded its genomic laboratory with the addition of an Element Biosciences AVITI System to its fleet of sequencers.

Tens of thousands of people with Jewish ancestry who are more likely to carry a genetic fault that can increase the risk of developing some cancers will receive genetic testing through a new programme announced by the NHS in England.

Hologic has announced that its new Genius Digital Diagnostics System with the Genius Cervical AI algorithm has received clearance from the U.S. Food and Drug Administration (FDA). The Genius system combines deep-learning-based artificial intelligence (AI) with advanced volumetric imaging technology to help identify pre-cancerous lesions and cervical cancer cells.

The US Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) is to reclassify the highest risk in vitro diagnostic (IVD) devices, saying it is aiming to increase competition and increase access.

Aston University has hosted an event to celebrate the launch of SPARK The Midlands, a network which aims to bridge the gap between medical research discoveries of novel therapeutics, medical devices and diagnostics, and real-world clinical use.

Beckman Coulter Diagnostics will unveil its new DxC 500 AU Chemistry Analyzer, an automated clinical chemistry analyser, at Medlab Middle East in Dubai, taking place 5-8 February. The new analyser expands the company’s portfolio with proven Six Sigma performance and aims to complement hub laboratories by advancing the capabilities of satellite and independent community hospital sites.

The use of a blood biomarker test in a new diagnostic approach is offering fresh potential to increase the speed and accessibility of testing for polycystic ovary syndrome (PCOS), in a first-of-its-kind use for the diagnostic tool.

The North East Innovation Lab is expanding its portfolio and focusing its expertise in developing diagnostic tests for patients with autoimmune disease. The laboratory, part of Newcastle Hospitals, is working with the ‘golden triangle’ of industry, academia and the NHS to bring new and improved tests to market for inflammatory conditions.

Yokogawa Electric Corporation has unveiled the new CQ3000, a high-content analysis system for capturing high-definition 3D microscopic images of live cell cultures. Expanding the company’s CellVoyager family of products, the CQ3000 will be launched commercially later in 2024.

The UK Health Security Agency (UKHSA) has published its Pathogen Genomics Strategy, laying out a five-year plan for the organisation’s role in the wider delivery of pathogen genomics to prepare for and respond to infectious disease threats to public health.

Bio-Techne Corporation has announced that Advanced Cell Diagnostics (ACD), a Bio-Techne spatial biology brand, has set a new standard with the development of a next-generation, protease-free RNAscope spatial multiomics workflow.

BD (Becton, Dickinson and Company) and artificial intelligence (AI)-based digital diagnostics firm Techcyte have announced a strategic collaboration agreement to offer an AI-based algorithm that guides cytologists and pathologists to efficiently and effectively identify evidence of cervical cancer and precancer using whole-slide imaging.